Details of Drug-Metabolizing Enzyme (DME)
| General Information of DME (ID: DME1737) | |||||
|---|---|---|---|---|---|
| DME Name | Unclear metabolic mechanism (DME-unclear), Fusobacterium canifelinum | ||||
| Gene Name | DME-unclear | ||||
| Lineage | Species: Fusobacterium canifelinum (Click to Show/Hide the Complete Species Lineage) | ||||
| Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Pathway/Function) of This DME | |||||
| Tissue Distribution | Primarily distributed in human gut. | ||||
| Full List of Drug(s) Metabolized by This DME | |||||
|---|---|---|---|---|---|
| Drugs in Phase 2 Clinical Trial | Click to Show/Hide the Full List of Drugs: 1 Drugs | ||||
Q-100154 |
Drug Info | Phase 2 | Hepatocellular carcinoma | ICD11: 2C12 | [1] |
| Preclinical/investigative Agents | Click to Show/Hide the Full List of Drugs: 3 Drugs | ||||
Kalopanaxsaponin H |
Drug Info | Investigative | Diabetes mellitus | ICD11: 5A10 | [2] |
Kalopanaxsaponin I |
Drug Info | Investigative | Prostate cancer | ICD11: 2C82 | [2] |
Kalopanaxsaponin K |
Drug Info | Investigative | Rheumatoid arthritis | ICD11: FA20 | [2] |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

